89 results on '"Prasadan K"'
Search Results
2. Transfection Alters Ion Transport in MDCK Cells
- Author
-
Kaji, D.M., Bates, J., Goyzueta, J.D., Prasadan, K., Yu, H., and Kumar, S.
- Published
- 1996
- Full Text
- View/download PDF
3. Regulation of β Cell Proliferation by Targeting SMAD2
- Author
-
Gaffar, I., primary, Xiao, X., additional, El-Gohary, Y., additional, Wiersch, J., additional, Prasadan, K., additional, Guo, P., additional, Shiota, C., additional, and Gittes, G., additional
- Published
- 2014
- Full Text
- View/download PDF
4. Immunologic Regulation of Pancreatic Ductal Invasion of Islets
- Author
-
Wiersch, J., primary, Marr, M., additional, Gohary, Y., additional, Xiao, X., additional, Guo, P., additional, Prasadan, K., additional, Shiota, C., additional, Piganelli, J., additional, and Gittes, G., additional
- Published
- 2013
- Full Text
- View/download PDF
5. Pancreatic Duct Glands: Are They the Missing Pancreas Specific Stem Cells
- Author
-
El-Gohary, Y., primary, Xiao, X., additional, Guo, P., additional, Wiersch, J., additional, Prasadan, K., additional, Shiota, C., additional, and Gittes, G., additional
- Published
- 2013
- Full Text
- View/download PDF
6. Transfection alters ion transport in MDCK cells
- Author
-
Goyzueta Jd, Yu H, Kaji Dm, Bates J, Prasadan K, and Satish Kumar
- Subjects
animal structures ,DNA, Complementary ,Physiology ,viruses ,Biophysics ,Cytomegalovirus ,Gene Expression ,Simian virus 40 ,Biology ,Transfection ,Ouabain ,Cell Line ,chemistry.chemical_compound ,Plasmid ,Mucoproteins ,Complementary DNA ,Uromodulin ,medicine ,RNA, Messenger ,Ion transporter ,Ion Transport ,fungi ,Cell Biology ,Molecular biology ,chemistry ,embryonic structures ,Potassium ,Cotransporter ,Bumetanide ,DNA ,medicine.drug - Abstract
In the course of an investigation into the effect of Tamm-Horsfall protein (THP) on ion transport, we performed stable transfection of THP into MDCK cells using the SV40 or the cytomegalovirus (CMV) promoter. As controls, we transfected MDCK cells with an ``empty'' plasmid containing SV40 or CMV promoter but without THP cDNA. In another set of controls, we subjected cells to transfection procedures without DNA (mock transfection). K influx was not altered in cells subjected to mock transfection procedures without DNA, but both ouabain sensitive (OS) and ouabain resistant (OR) components of K influx were diminished in cells transfected with THP cDNA using either SV40 or CMV promoter. However, K influx was also reduced in cells transfected with a control plasmid containing either the SV40 promoter alone, or the CMV promoter alone, without the THP cDNA. Thus, the transport alterations were caused by transfection and not by THP. The reduction in ouabain-sensitive K influx was accompanied by a proportional reduction in the abundance of Na-K pump units as assessed by [3H] ouabain binding. [3H] bumetanide binding, a measure of the number of functioning NaK2Cl cotransporter sites, was reduced pari passu with the reduction in bumetanide-sensitive K influx. These results highlight the possibility that alterations in properties of transfected cells may not be solely due to the presence of transfected protein, but the result of some process associated with transfection itself. Without appropriate controls to evaluate this possibility, results of transfection studies are subject to potentially faulty and misleading interpretation.
- Published
- 1996
7. Three-Dimensional Analysis of the Islet Vasculature
- Author
-
El-Gohary, Y., primary, Sims-Lucas, S., additional, Lath, N., additional, Tulachan, S., additional, Guo, P., additional, Xiao, X., additional, Welsh, C., additional, Paredes, J., additional, Wiersch, J., additional, Prasadan, K., additional, Shiota, C., additional, and Gittes, G.K., additional
- Published
- 2012
- Full Text
- View/download PDF
8. Pancreatic Ducts and Alpha Cells Contribute to New Beta Cells Under Normal Physiological Conditions and During Pancreatic Regeneration
- Author
-
El-Gohary, Y., primary, Tulachan, S., additional, Prasadan, K., additional, Shiota, C., additional, Guo, P., additional, and Gittes, G., additional
- Published
- 2012
- Full Text
- View/download PDF
9. Blood Flow And Oxygen Signaling Regulate Early Endocrine Development
- Author
-
Paredes, J.L., primary, Prasadan, K., additional, Sheppard, A., additional, and Gittes, G.K., additional
- Published
- 2011
- Full Text
- View/download PDF
10. 47
- Author
-
Shah, S.R., primary, Prasadan, K., additional, Yew, K., additional, Tulachan, S., additional, Guo, P., additional, Koizumi, M., additional, and Gittes, G.K., additional
- Published
- 2007
- Full Text
- View/download PDF
11. Pleiotrophin signaling in pancreatic organogenesis and differentiation
- Author
-
Li, Z., primary, Mehta, S.S., additional, Prasadan, K., additional, Hembree, M., additional, Holcomb, G.W., additional, Ostlie, D.J., additional, Snyder, C.L., additional, and Gittes, G.K., additional
- Published
- 2003
- Full Text
- View/download PDF
12. 47: Overlapping roles for glucagon and GLP-1 in insulin-cell differentiation
- Author
-
Shah, S.R., Prasadan, K., Yew, K., Tulachan, S., Guo, P., Koizumi, M., and Gittes, G.K.
- Published
- 2007
- Full Text
- View/download PDF
13. Acinar to β-like cell conversion through inhibition of focal adhesion kinase.
- Author
-
Dahiya S, Saleh M, Rodriguez UA, Rajasundaram D, R Arbujas J, Hajihassani A, Yang K, Sehrawat A, Kalsi R, Yoshida S, Prasadan K, Lickert H, Hu J, Piganelli JD, Gittes GK, and Esni F
- Subjects
- Animals, Mice, Male, Insulin metabolism, Cell Transdifferentiation, Focal Adhesion Protein-Tyrosine Kinases metabolism, Focal Adhesion Protein-Tyrosine Kinases antagonists & inhibitors, Mice, Inbred C57BL, Protein Kinase Inhibitors pharmacology, Islets of Langerhans metabolism, Insulin-Secreting Cells metabolism, Acinar Cells metabolism, Diabetes Mellitus, Experimental
- Abstract
Insufficient functional β-cell mass causes diabetes; however, an effective cell replacement therapy for curing diabetes is currently not available. Reprogramming of acinar cells toward functional insulin-producing cells would offer an abundant and autologous source of insulin-producing cells. Our lineage tracing studies along with transcriptomic characterization demonstrate that treatment of adult mice with a small molecule that specifically inhibits kinase activity of focal adhesion kinase results in trans-differentiation of a subset of peri-islet acinar cells into insulin producing β-like cells. The acinar-derived insulin-producing cells infiltrate the pre-existing endocrine islets, partially restore β-cell mass, and significantly improve glucose homeostasis in diabetic mice. These findings provide evidence that inhibition of the kinase activity of focal adhesion kinase can convert acinar cells into insulin-producing cells and could offer a promising strategy for treating diabetes., (© 2024. The Author(s).)
- Published
- 2024
- Full Text
- View/download PDF
14. Biliary atresia is associated with polygenic susceptibility in ciliogenesis and planar polarity effector genes.
- Author
-
Glessner JT, Ningappa MB, Ngo KA, Zahid M, So J, Higgs BW, Sleiman PMA, Narayanan T, Ranganathan S, March M, Prasadan K, Vaccaro C, Reyes-Mugica M, Velazquez J, Salgado CM, Ebrahimkhani MR, Schmitt L, Rajasundaram D, Paul M, Pellegrino R, Gittes GK, Li D, Wang X, Billings J, Squires R, Ashokkumar C, Sharif K, Kelly D, Dhawan A, Horslen S, Lo CW, Shin D, Subramaniam S, Hakonarson H, and Sindhi R
- Subjects
- Child, Animals, Mice, Humans, Genome-Wide Association Study, Genetic Predisposition to Disease, Zebrafish genetics, Canada, Biliary Atresia genetics
- Abstract
Background & Aims: Biliary atresia (BA) is poorly understood and leads to liver transplantation (LT), with the requirement for and associated risks of lifelong immunosuppression, in most children. We performed a genome-wide association study (GWAS) to determine the genetic basis of BA., Methods: We performed a GWAS in 811 European BA cases treated with LT in US, Canadian and UK centers, and 4,654 genetically matched controls. Whole-genome sequencing of 100 cases evaluated synthetic association with rare variants. Functional studies included whole liver transcriptome analysis of 64 BA cases and perturbations in experimental models., Results: A GWAS of common single nucleotide polymorphisms (SNPs), i.e. allele frequencies >1%, identified intronic SNPs rs6446628 in AFAP1 with genome-wide significance (p = 3.93E-8) and rs34599046 in TUSC3 at sub-threshold genome-wide significance (p = 1.34E-7), both supported by credible peaks of neighboring SNPs. Like other previously reported BA-associated genes, AFAP1 and TUSC3 are ciliogenesis and planar polarity effectors (CPLANE). In gene-set-based GWAS, BA was associated with 6,005 SNPs in 102 CPLANE genes (p = 5.84E-15). Compared with non-CPLANE genes, more CPLANE genes harbored rare variants (allele frequency <1%) that were assigned Human Phenotype Ontology terms related to hepatobiliary anomalies by predictive algorithms, 87% vs. 40%, p <0.0001. Rare variants were present in multiple genes distinct from those with BA-associated common variants in most BA cases. AFAP1 and TUSC3 knockdown blocked ciliogenesis in mouse tracheal cells. Inhibition of ciliogenesis caused biliary dysgenesis in zebrafish. AFAP1 and TUSC3 were expressed in fetal liver organoids, as well as fetal and BA livers, but not in normal or disease-control livers. Integrative analysis of BA-associated variants and liver transcripts revealed abnormal vasculogenesis and epithelial tube formation, explaining portal vein anomalies that co-exist with BA., Conclusions: BA is associated with polygenic susceptibility in CPLANE genes. Rare variants contribute to polygenic risk in vulnerable pathways via unique genes., Impact and Implications: Liver transplantation is needed to cure most children born with biliary atresia, a poorly understood rare disease. Transplant immunosuppression increases the likelihood of life-threatening infections and cancers. To improve care by preventing this disease and its progression to transplantation, we examined its genetic basis. We find that this disease is associated with both common and rare mutations in highly specialized genes which maintain normal communication and movement of cells, and their organization into bile ducts and blood vessels during early development of the human embryo. Because defects in these genes also cause other birth defects, our findings could lead to preventive strategies to lower the incidence of biliary atresia and potentially other birth defects., (Copyright © 2023 The Authors. Published by Elsevier B.V. All rights reserved.)
- Published
- 2023
- Full Text
- View/download PDF
15. Chemical pancreatectomy in non-human primates ablates the acini and ducts and enhances beta-cell function.
- Author
-
Kalsi RS, Kreger AM, Saleh M, Yoshida S, Sharma K, Fusco J, Saloman JL, Zhang T, Thomas M, Sehrawat A, Wang Y, Reif J, Mills J, Raad S, Zengin B, Gomez A, Singhi A, Tadros S, Slivka A, Esni F, Prasadan K, and Gittes G
- Subjects
- Animals, Pilot Projects, Primates, Pain, Chronic Disease, Pancreatectomy methods, Pancreatitis, Chronic surgery
- Abstract
Chronic pancreatitis is a debilitating disease affecting millions worldwide. These patients suffer from bouts of severe pain that are minimally relieved by pain medications and may necessitate major surgeries with high morbidity and mortality. Previously, we demonstrated that "chemical pancreatectomy," a pancreatic intraductal infusion of dilute acetic acid solution, ablated the exocrine pancreas while preserving the endocrine pancreas. Notably, chemical pancreatectomy resolved chronic inflammation, alleviated allodynia in the cerulein pancreatitis model, and improved glucose homeostasis. Herein, we extensively tested the feasibility of a chemical pancreatectomy in NHPs and validated our previously published pilot study. We did serial computed tomography (CT) scans of the abdomen and pelvis, analyzed dorsal root ganglia, measured serum enzymes, and performed histological and ultrastructural assessments and pancreatic endocrine function assays. Based on serial CT scans, chemical pancreatectomy led to the loss of pancreatic volume. Immunohistochemistry and transmission electron microscopy demonstrated exocrine pancreatic ablation with endocrine islet preservation. Importantly, chemical pancreatectomy did not increase pro-nociceptive markers in harvested dorsal root ganglia. Also, chemical pancreatectomy improved insulin secretion to supranormal levels in vivo and in vitro. Thus, this study may provide a foundation for translating this procedure to patients with chronic pancreatitis or other conditions requiring a pancreatectomy., (© 2023. The Author(s).)
- Published
- 2023
- Full Text
- View/download PDF
16. Bone-marrow derived cells do not contribute to new beta-cells in the inflamed pancreas.
- Author
-
Jiang Y, Wiersch J, Wu W, Qian J, Adama MPR, Wu N, Yang W, Chen C, Zhu L, Prasadan K, Gittes GK, and Xiao X
- Subjects
- Mice, Animals, Acute Disease, Bone Marrow Cells, Pancreas, Bone Marrow, Pancreatitis
- Abstract
The contribution of bone-marrow derived cells (BMCs) to a newly formed beta-cell population in adults is controversial. Previous studies have only used models of bone marrow transplantation from sex-mismatched donors (or other models of genetic labeling) into recipient animals that had undergone irradiation. This approach suffers from the significant shortcoming of the off-target effects of irradiation. Partial pancreatic duct ligation (PDL) is a mouse model of acute pancreatitis with a modest increase in beta-cell number. However, the possibility that recruited BMCs in the inflamed pancreas may convert into beta-cells has not been examined. Here, we used an irradiation-free model to track the fate of the BMCs from the donor mice. A ROSA-mTmG red fluorescent mouse was surgically joined to an INS1
Cre knock-in mouse by parabiosis to establish a mixed circulation. PDL was then performed in the INS1Cre mice 2 weeks after parabiosis, which was one week after establishment of the stable blood chimera. The contribution of red cells from ROSA-mTmG mice to beta-cells in INS1Cre mouse was evaluated based on red fluorescence, while cell fusion was evaluated by the presence of green fluorescence in beta-cells. We did not detect any red or green insulin+ cells in the INS1Cre mice, suggesting that there was no contribution of BMCs to the newly formed beta-cells, either by direct differentiation, or by cell fusion. Thus, the contribution of BMCs to beta-cells in the inflamed pancreas should be minimal, if any., Competing Interests: The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest., (Copyright © 2023 Jiang, Wiersch, Wu, Qian, Adama, Wu, Yang, Chen, Zhu, Prasadan, Gittes and Xiao.)- Published
- 2023
- Full Text
- View/download PDF
17. Polarized macrophages promote gestational beta cell growth through extracellular signal-regulated kinase 5 signalling.
- Author
-
Jiang Y, Chen A, Kline D, Liu Q, Ma J, Wang Y, Zhang T, Qian J, Nelson L, Prasadan K, Hu B, Gittes GK, and Xiao X
- Subjects
- Animals, Cell Proliferation, Female, Macrophages metabolism, Mice, Placenta Growth Factor metabolism, Epidermal Growth Factor metabolism, Epidermal Growth Factor pharmacology, Mitogen-Activated Protein Kinase 7 metabolism
- Abstract
Aim: To show that depletion of pancreatic macrophages impairs gestational beta cell proliferation and leads to glucose intolerance., Materials and Methods: Genetic animal models were applied to study the effects of depletion of pancreatic macrophges on gestational beta-cell proliferaiton and glucose response. The crosstalk between macrophages and beta-cells was studied in vivo using beta-cell-specific extracellular-signal-regulated kinase 5 (ERK5) knockout and epidermal growth receptor (EGFR) knockout mice, and in vitro using a co-culture system., Results: Beta cell-derived placental growth factor (PlGF) recruited naïve macrophages and polarized them towards an M2-like phenotype. These macrophages then secreted epidermal growth factor (EGF), which activated extracellular signal-regulated kinase 5 (ERK5) signalling in beta cells to promote gestational beta cell proliferation. On the other hand, activation of ERK5 signalling in beta cells likely, in turn, enhanced the production and secretion of PlGF by beta cells., Conclusions: Our study shows a regulatory loop between macrophages and beta cells through PlGF/EGF/ERK5 signalling cascades to regulate gestational beta cell growth., (© 2022 John Wiley & Sons Ltd.)
- Published
- 2022
- Full Text
- View/download PDF
18. Alpha-to-beta cell trans-differentiation for treatment of diabetes.
- Author
-
Saleh M, Gittes GK, and Prasadan K
- Subjects
- Animals, Diabetes Mellitus, Type 1 pathology, Diabetes Mellitus, Type 2 pathology, Humans, Insulin metabolism, Insulin-Secreting Cells metabolism, Insulin-Secreting Cells pathology, Mice, Transcription Factors metabolism, Cell Transdifferentiation, Cell- and Tissue-Based Therapy, Diabetes Mellitus, Type 1 therapy, Diabetes Mellitus, Type 2 therapy
- Abstract
Diabetes mellitus is a significant cause of morbidity and mortality in the United States and worldwide. According to the CDC, in 2017, ∼34.2 million of the American population had diabetes. Also, in 2017, diabetes was the seventh leading cause of death and has become the number one biomedical financial burden in the United States. Insulin replacement therapy and medications that increase insulin secretion and improve insulin sensitivity are the main therapies used to treat diabetes. Unfortunately, there is currently no radical cure for the different types of diabetes. Loss of β cell mass is the end result that leads to both type 1 and type 2 diabetes. In the past decade, there has been an increased effort to develop therapeutic strategies to replace the lost β cell mass and restore insulin secretion. α cells have recently become an attractive target for replacing the lost β cell mass, which could eventually be a potential strategy to cure diabetes. This review highlights the advantages of using α cells as a source for generating new β cells, the various investigative approaches to convert α cells into insulin-producing cells, and the future prospects and problems of this promising diabetes therapeutic strategy., (© 2021 The Author(s).)
- Published
- 2021
- Full Text
- View/download PDF
19. β-cell Smad2 null mice have improved β-cell function and are protected from diet-induced hyperglycemia.
- Author
-
Saleh M, Mohamed NA, Sehrawat A, Zhang T, Thomas M, Wang Y, Kalsi R, Molitoris J, Prasadan K, and Gittes GK
- Subjects
- Animals, Diet, High-Fat adverse effects, Hyperglycemia chemically induced, Hyperglycemia genetics, Mice, Mice, Knockout, Smad2 Protein genetics, Hyperglycemia metabolism, Insulin Secretion, Insulin-Secreting Cells metabolism, Signal Transduction, Smad2 Protein metabolism
- Abstract
Understanding signaling pathways that regulate pancreatic β-cell function to produce, store, and release insulin, as well as pathways that control β-cell proliferation, is vital to find new treatments for diabetes mellitus. Transforming growth factor-beta (TGF-β) signaling is involved in a broad range of β-cell functions. The canonical TGF-β signaling pathway functions through intracellular smads, including smad2 and smad3, to regulate cell development, proliferation, differentiation, and function in many organs. Here, we demonstrate the role of TGF-β/smad2 signaling in regulating mature β-cell proliferation and function using β-cell-specific smad2 null mutant mice. β-cell-specific smad2-deficient mice exhibited improved glucose clearance as demonstrated by glucose tolerance testing, enhanced in vivo and ex vivo glucose-stimulated insulin secretion, and increased β-cell mass and proliferation. Furthermore, when these mice were fed a high-fat diet to induce hyperglycemia, they again showed improved glucose tolerance, insulin secretion, and insulin sensitivity. In addition, ex vivo analysis of smad2-deficient islets showed that they displayed increased glucose-stimulated insulin secretion and upregulation of genes involved in insulin synthesis and insulin secretion. Thus, we conclude that smad2 could represent an attractive therapeutic target for type 2 diabetes mellitus., Competing Interests: Conflict of interest The authors declare that they have no conflicts of interest with the contents of this article., (Copyright © 2021. Published by Elsevier Inc.)
- Published
- 2021
- Full Text
- View/download PDF
20. Pancreatic Duct Infusion: An Effective and Selective Method of Drug and Viral Delivery.
- Author
-
Fusco JC, Congde C, Xiao X, Prasadan K, Ricks D, and Gittes GK
- Subjects
- Duodenum, Humans, Pancreas surgery, Pancreatic Ducts, Pancreatic Neoplasms, Pharmaceutical Preparations
- Abstract
The pancreas is a bifunctional organ with both endocrine and exocrine components. A number of pathologies can afflict the pancreas, including diabetes, pancreatitis, and pancreatic cancer. All three of these diseases mark active areas of study, not only to develop immediate therapy, but also to better understand their pathophysiology. There are few tools to further these areas of study. Pancreatic duct infusion is an important technique that can allow for lineage tracing, gene introduction, and cell line-specific targeting. The technique requires the intricate dissection of the second portion of the duodenum and ampulla, followed by the occlusion of the bile duct and the cannulation of the pancreatic duct. Although the technique is technically challenging at first, the applications are myriad. Ambiguity in the specifics of the procedure between groups highlighted the need for a standard protocol. This work describes the expression of a green fluorescent protein (GFP) within the pancreas after the pancreatic duct infusion of a viral vector expressing GFP versus a sham surgery. The infusion and therefore expression is specific to the pancreas, without expression present in any other tissue type.
- Published
- 2021
- Full Text
- View/download PDF
21. Mechanisms of Impaired Lung Development and Ciliation in Mannosidase-1-Alpha-2 ( Man1a2 ) Mutants.
- Author
-
Ningappa M, Adenuga M, Ngo KA, Mohamed N, Narayanan T, Prasadan K, Ashokkumar C, Das J, Schmitt L, Hartman H, Sehrawat A, Salgado CM, Reyes-Mugica M, Gittes GK, Lo CW, Subramaniam S, and Sindhi R
- Abstract
Background: Ciliary defects cause heterogenous phenotypes related to mutation burden which lead to impaired development. A previously reported homozygous deletion in the Man1a2 gene causes lethal respiratory failure in newborn pups and decreased lung ciliation compared with wild type (WT) pups. The effects of heterozygous mutation, and the potential for rescue are not known., Purpose: We hypothesized that survival and lung ciliation, (a) would decrease progressively in Man1a2
+/- heterozygous and Man1a2-/- null newborn pups compared with WT, and (b) could be enhanced by gestational treatment with N-Acetyl-cysteine (NAC), an antioxidant., Methods: Man1a 2+/- adult mice were fed NAC or placebo from a week before breeding through gestation. Survival of newborn pups was monitored for 24 h. Lungs, liver and tails were harvested for morphology, genotyping, and transcriptional profiling., Results: Survival ( p = 0.0001, Kaplan-Meier) and percent lung ciliation ( p = 0.0001, ANOVA) measured by frequency of Arl13b+ respiratory epithelial cells decreased progressively, as hypothesized. Compared with placebo, gestational NAC treatment enhanced (a) lung ciliation in pups with each genotype, (b) survival in heterozygous pups ( p = 0.017) but not in WT or null pups. Whole transcriptome of lung but not liver demonstrated patterns of up- and down-regulated genes that were identical in living heterozygous and WT pups, and completely opposite to those in dead heterozygous and null pups. Systems biology analysis enabled reconstruction of protein interaction networks that yielded functionally relevant modules and their interactions. In these networks, the mutant Man1a2 enzyme contributes to abnormal synthesis of proteins essential for lung development. The associated unfolded protein, hypoxic and oxidative stress responses can be mitigated with NAC. Comparisons with the developing human fetal lung transcriptome show that NAC likely restores normal vascular and epithelial tube morphogenesis in Man1a2 mutant mice., Conclusion: Survival and lung ciliation in the Man1a2 mutant mouse, and its improvement with N-Acetyl cysteine is genotype-dependent. NAC-mediated rescue depends on the central role for oxidative and hypoxic stress in regulating ciliary function and organogenesis during development., Competing Interests: The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest., (Copyright © 2021 Ningappa, Adenuga, Ngo, Mohamed, Narayanan, Prasadan, Ashokkumar, Das, Schmitt, Hartman, Sehrawat, Salgado, Reyes-Mugica, Gittes, Lo, Subramaniam and Sindhi.)- Published
- 2021
- Full Text
- View/download PDF
22. Conversion of α-Cells to β-Cells in the Postpartum Mouse Pancreas Involves Lgr5 Progeny.
- Author
-
Rodriguez UA, Socorro M, Criscimanna A, Martins CP, Mohamed N, Hu J, Prasadan K, Gittes GK, and Esni F
- Subjects
- Animals, Apoptosis, Cell Differentiation, Female, Mice, Mice, Inbred C57BL, Cell Lineage, Glucagon-Secreting Cells cytology, Insulin-Secreting Cells cytology, Pancreas cytology, Postpartum Period metabolism, Receptors, G-Protein-Coupled physiology, Stem Cells cytology
- Abstract
In contrast to the skin and the gut, where somatic stem cells and their niche are well characterized, a definitive pancreatic multipotent cell population in the adult pancreas has yet to be revealed. Of particular interest is whether such cells may be endogenous in patients with diabetes, and if so, can they be used for therapeutic purposes? In the current study, we used two separate reporter lines to target Cre-recombinase expression to the Lgr5- or glucagon-expressing cells in the pancreas. We provide evidence for the existence of a population of cells within and in the proximity of the ducts that transiently express the stem-cell marker Lgr5 during late gestational stages. Careful timing of tamoxifen treatment in Lgr5
EGFP-IRES-CreERT2 ;R26Tomato mice allowed us to show that these Lgr5 -expressing progenitor cells can differentiate into α-cells during pregnancy. Furthermore, we report on a spontaneous lineage conversion of α- to β-cells specifically after parturition. The contribution of Lgr5 progeny to the β-cell compartment through an α-cell intermediate phase early after pregnancy appears to be part of a novel mechanism that would counterbalance against excessive β-cell mass reduction during β-cell involution., (© 2021 by the American Diabetes Association.)- Published
- 2021
- Full Text
- View/download PDF
23. Insulin-positive ductal cells do not migrate into preexisting islets during pregnancy.
- Author
-
Liu Q, Jiang Y, Zhu L, Qian J, Wang C, Yang T, Prasadan K, Gittes GK, and Xiao X
- Subjects
- Animals, Biomarkers, Cell Differentiation, Computational Biology methods, Extracellular Matrix, Female, Fluorescent Antibody Technique, Gene Expression Profiling, Gene Expression Regulation, Humans, Immunophenotyping, Mice, Mice, Transgenic, Pregnancy, Cell Movement, Insulin metabolism, Insulin-Secreting Cells metabolism, Islets of Langerhans metabolism, Pancreatic Ducts cytology
- Abstract
The adult pancreatic ductal system was suggested to harbor facultative beta-cell progenitors similar to the embryonic pancreas, and the appearance of insulin-positive duct cells has been used as evidence for natural duct-to-beta-cell reprogramming. Nevertheless, the phenotype and fate of these insulin-positive cells in ducts have not been determined. Here, we used a cell-tagging dye, CFDA-SE, to permanently label pancreatic duct cells through an intraductal infusion technique. Representing a time when significant increases in beta-cell mass occur, pregnancy was later induced in these CFDA-SE-treated mice to assess the phenotype and fate of the insulin-positive cells in ducts. We found that a small portion of CFDA-SE-labeled duct cells became insulin-positive, but they were not fully functional beta-cells based on the in vitro glucose response and the expression levels of key beta-cell genes. Moreover, these insulin-positive cells in ducts expressed significantly lower levels of genes associated with extracellular matrix degradation and cell migration, which may thus prevent their budding and migration into preexisting islets. A similar conclusion was reached through analysis of the Gene Expression Omnibus database for both mice and humans. Together, our data suggest that the contribution of duct cells to normal beta-cells in adult islets is minimal at best.
- Published
- 2021
- Full Text
- View/download PDF
24. Chemical pancreatectomy treats chronic pancreatitis while preserving endocrine function in preclinical models.
- Author
-
Saleh M, Sharma K, Kalsi R, Fusco J, Sehrawat A, Saloman JL, Guo P, Zhang T, Mohamed N, Wang Y, Prasadan K, and Gittes GK
- Subjects
- Animals, Disease Models, Animal, Macaca fascicularis, Male, Mice, Mice, Transgenic, Acetic Acid pharmacology, Pancreatectomy, Pancreatic Ducts, Pancreatitis, Chronic therapy
- Abstract
Chronic pancreatitis affects over 250,000 people in the US and millions worldwide. It is associated with chronic debilitating pain, pancreatic exocrine failure, and high risk of pancreatic cancer and usually progresses to diabetes. Treatment options are limited and ineffective. We developed a new potential therapy, wherein a pancreatic ductal infusion of 1%-2% acetic acid in mice and nonhuman primates resulted in a nonregenerative, near-complete ablation of the exocrine pancreas, with complete preservation of the islets. Pancreatic ductal infusion of acetic acid in a mouse model of chronic pancreatitis led to resolution of chronic inflammation and pancreatitis-associated pain. Furthermore, acetic acid-treated animals showed improved glucose tolerance and insulin secretion. The loss of exocrine tissue in this procedure would not typically require further management in patients with chronic pancreatitis because they usually have pancreatic exocrine failure requiring dietary enzyme supplements. Thus, this procedure, which should be readily translatable to humans through an endoscopic retrograde cholangiopancreatography (ERCP), may offer a potential innovative nonsurgical therapy for chronic pancreatitis that relieves pain and prevents the progression of pancreatic diabetes.
- Published
- 2021
- Full Text
- View/download PDF
25. Biliary-Atresia-Associated Mannosidase-1-Alpha-2 Gene Regulates Biliary and Ciliary Morphogenesis and Laterality.
- Author
-
So J, Ningappa M, Glessner J, Min J, Ashokkumar C, Ranganathan S, Higgs BW, Li D, Sun Q, Schmitt L, Biery AC, Dobrowolski S, Trautz C, Fuhrman L, Schwartz MC, Klena NT, Fusco J, Prasadan K, Adenuga M, Mohamed N, Yan Q, Chen W, Horne W, Dhawan A, Sharif K, Kelly D, Squires RH, Gittes GK, Hakonarson H, Morell V, Lo C, Subramaniam S, Shin D, and Sindhi R
- Abstract
Background/aims: Infectious and genetic factors are invoked, respectively in isolated biliary atresia (BA), or syndromic BA, with major extrahepatic anomalies. However, isolated BA is also associated with minor extrahepatic gut and cardiovascular anomalies and multiple susceptibility genes, suggesting common origins., Methods: We investigated novel susceptibility genes with genome-wide association, targeted sequencing and tissue staining in BA requiring liver transplantation, independent of BA subtype. Candidate gene effects on morphogenesis, developmental pathways, and ciliogenesis, which regulates left-right patterning were investigated with zebrafish knockdown and mouse knockout models, mouse airway cell cultures, and liver transcriptome analysis., Results: Single nucleotide polymorphisms in Mannosidase-1-α-2 ( MAN1A2 ) were significantly associated with BA and with other polymorphisms known to affect MAN1A2 expression but were not differentially enriched in either BA subtype. In zebrafish embryos, man1a2 knockdown caused poor biliary network formation, ciliary dysgenesis in Kupffer's vesicle, cardiac and liver heterotaxy, and dysregulated egfra and other developmental genes. Suboptimal man1a2 knockdown synergized with suboptimal EGFR signaling or suboptimal knockdown of the EGFR pathway gene, adenosine-ribosylation-factor-6, which had minimal effects individually, to reproduce biliary defects but not heterotaxy. In cultured mouse airway epithelium, Man1a2 knockdown arrested ciliary development and motility. Man1a2
-/- mice, which experience respiratory failure, also demonstrated portal and bile ductular inflammation. Human BA liver and Man1a2-/- liver exhibited reduced Man1a2 expression and dysregulated ciliary genes, known to cause multisystem human laterality defects., Conclusion: BA requiring transplantation associates with sequence variants in MAN1A2 . man1a2 regulates laterality, in addition to hepatobiliary morphogenesis, by regulating ciliogenesis in zebrafish and mice, providing a novel developmental basis for multisystem defects in BA., (Copyright © 2020 So, Ningappa, Glessner, Min, Ashokkumar, Ranganathan, Higgs, Li, Sun, Schmitt, Biery, Dobrowolski, Trautz, Fuhrman, Schwartz, Klena, Fusco, Prasadan, Adenuga, Mohamed, Yan, Chen, Horne, Dhawan, Sharif, Kelly, Squires, Gittes, Hakonarson, Morell, Lo, Subramaniam, Shin and Sindhi.)- Published
- 2020
- Full Text
- View/download PDF
26. SMAD7 enhances adult β-cell proliferation without significantly affecting β-cell function in mice.
- Author
-
Sehrawat A, Shiota C, Mohamed N, DiNicola J, Saleh M, Kalsi R, Zhang T, Wang Y, Prasadan K, and Gittes GK
- Subjects
- Animals, Female, Glucose pharmacology, Male, Mice, Mice, Knockout, Signal Transduction, Sweetening Agents pharmacology, Transforming Growth Factor beta genetics, Cell Proliferation, Insulin physiology, Insulin Secretion drug effects, Insulin-Secreting Cells cytology, Insulin-Secreting Cells physiology, Smad7 Protein physiology, Transforming Growth Factor beta metabolism
- Abstract
The interplay between the transforming growth factor β (TGF-β) signaling proteins, SMAD family member 2 (SMAD2) and 3 (SMAD3), and the TGF-β-inhibiting SMAD, SMAD7, seems to play a vital role in proper pancreatic endocrine development and also in normal β-cell function in adult pancreatic islets. Here, we generated conditional SMAD7 knockout mice by crossing insulin1
Cre mice with SMAD7fx/fx mice. We also created a β cell-specific SMAD7-overexpressing mouse line by crossing insulin1Dre mice with HPRT-SMAD7/RosaGFP mice. We analyzed β-cell function in adult islets when SMAD7 was either absent or overexpressed in β cells. Loss of SMAD7 in β cells inhibited proliferation, and SMAD7 overexpression enhanced cell proliferation. However, alterations in basic glucose homeostasis were not detectable following either SMAD7 deletion or overexpression in β cells. Our results show that both the absence and overexpression of SMAD7 affect TGF-β signaling and modulates β-cell proliferation but does not appear to alter β-cell function. Reversible SMAD7 overexpression may represent an attractive therapeutic option to enhance β-cell proliferation without negative effects on β-cell function., (© 2020 Sehrawat et al.)- Published
- 2020
- Full Text
- View/download PDF
27. Placental growth factor in beta cells plays an essential role in gestational beta-cell growth.
- Author
-
Yang W, Jiang Y, Wang Y, Zhang T, Liu Q, Wang C, Swisher G, Wu N, Chao C, Prasadan K, Gittes GK, and Xiao X
- Subjects
- Animals, Cell Enlargement, Cell Proliferation, Female, Glucose metabolism, Macrophages metabolism, Mice, Inbred C57BL, Mice, Transgenic, Pregnancy, Insulin-Secreting Cells metabolism, Placenta Growth Factor metabolism
- Abstract
Objective: Pancreatic beta cells proliferate in response to metabolic requirements during pregnancy, while failure of this response may cause gestational diabetes. A member of the vascular endothelial growth factor family, placental growth factor (PlGF), typically plays a role in metabolic disorder and pathological circumstance. The expression and function of PlGF in the endocrine pancreas have not been reported and are addressed in the current study., Research Design and Methods: PlGF levels in beta cells were determined by immunostaining or ELISA in purified beta cells in non-pregnant and pregnant adult mice. An adeno-associated virus (AAV) serotype 8 carrying a shRNA for PlGF under the control of a rat insulin promoter (AAV-rat insulin promoter (RIP)-short hairpin small interfering RNA for PlGF (shPlGF)) was prepared and infused into mouse pancreas through the pancreatic duct to specifically knock down PlGF in beta cells, and its effects on beta-cell growth were determined by beta-cell proliferation, beta-cell mass and insulin release. A macrophage-depleting reagent, clodronate, was coapplied into AAV-treated mice to study crosstalk between beta cells and macrophages., Results: PlGF is exclusively produced by beta cells in the adult mouse pancreas. Moreover, PlGF expression in beta cells was significantly increased during pregnancy. Intraductal infusion of AAV-RIP-shPlGF specifically knocked down PlGF in beta cells, resulting in compromised beta-cell proliferation, reduced growth in beta-cell mass and impaired glucose tolerance during pregnancy. Mechanistically, PlGF depletion in beta cells reduced islet infiltration of trophic macrophages, which appeared to be essential for gestational beta-cell growth., Conclusions: Our study suggests that increased expression of PlGF in beta cells may trigger gestational beta-cell growth through recruited macrophages., Competing Interests: Competing interests: None declared., (© Author(s) (or their employer(s)) 2020. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ.)
- Published
- 2020
- Full Text
- View/download PDF
28. Evidence of a developmental origin for β-cell heterogeneity using a dual lineage-tracing technology.
- Author
-
Chen C, Shiota C, Agostinelli G, Ridley D, Jiang Y, Ma J, Prasadan K, Xiao X, and Gittes GK
- Subjects
- Animals, Cell Differentiation genetics, Cell Separation methods, Cells, Cultured, Homeodomain Proteins genetics, Homeodomain Proteins metabolism, Insulin-Secreting Cells metabolism, Mice, Mice, Inbred C57BL, Mice, Transgenic, Molecular Imaging methods, Organogenesis genetics, Pancreas embryology, Pancreas growth & development, Pancreas metabolism, Stem Cells metabolism, Trans-Activators genetics, Trans-Activators metabolism, Transcription Factors genetics, Transcription Factors metabolism, Cell Lineage genetics, Cell Tracking methods, Insulin-Secreting Cells cytology, Pancreas cytology, Stem Cells cytology
- Abstract
The Cre/loxP system has been used extensively in mouse models with a limitation of one lineage at a time. Differences in function and other properties among populations of adult β-cells is termed β-cell heterogeneity, which was recently associated with diabetic phenotypes. Nevertheless, the presence of a developmentally derived β-cell heterogeneity is unclear. Here, we have developed a novel dual lineage-tracing technology, using a combination of two recombinase systems, Dre/RoxP and Cre/LoxP, to independently trace green fluorescent Pdx1-lineage cells and red fluorescent Ptf1a-lineage cells in the developing and adult mouse pancreas. We detected a few Pdx1
+ /Ptf1a- lineage cells in addition to the vast majority of Pdx1+ /Ptf1a+ lineage cells in the pancreas. Moreover, Pdx1+ /Ptf1a+ lineage β-cells had fewer Ki-67+ proliferating β-cells, and expressed higher mRNA levels of insulin, Glut2, Pdx1, MafA and Nkx6.1, but lower CCND1 and CDK4 levels, compared with Pdx1+ /Ptf1a- lineage β-cells. Furthermore, more TSQ-high, SSC-high cells were detected in the Pdx1+ Ptf1a+ lineage population than in the Pdx1+ Ptf1a- lineage population. Together, these data suggest that differential activation of Ptf1a in the developing pancreas may correlate with this β-cell heterogeneity., Competing Interests: Competing interestsThe authors declare no competing or financial interests., (© 2019. Published by The Company of Biologists Ltd.)- Published
- 2019
- Full Text
- View/download PDF
29. Endogenous Reprogramming of Alpha Cells into Beta Cells, Induced by Viral Gene Therapy, Reverses Autoimmune Diabetes.
- Author
-
Xiao X, Guo P, Shiota C, Zhang T, Coudriet GM, Fischbach S, Prasadan K, Fusco J, Ramachandran S, Witkowski P, Piganelli JD, and Gittes GK
- Subjects
- Alloxan, Animals, Blood Glucose, Dependovirus metabolism, Gene Expression Profiling, Glucagon metabolism, Glucagon-Secreting Cells metabolism, Homeodomain Proteins metabolism, Humans, Hyperglycemia complications, Hyperglycemia pathology, Insulin metabolism, Insulin-Secreting Cells metabolism, Lectins, C-Type, Mice, Inbred C57BL, Mice, SCID, Receptors, Immunologic metabolism, Trans-Activators metabolism, Cellular Reprogramming, Diabetes Mellitus, Experimental pathology, Diabetes Mellitus, Experimental therapy, Diabetes Mellitus, Type 1 pathology, Diabetes Mellitus, Type 1 therapy, Genetic Therapy, Glucagon-Secreting Cells pathology, Insulin-Secreting Cells pathology
- Abstract
Successful strategies for treating type 1 diabetes need to restore the function of pancreatic beta cells that are destroyed by the immune system and overcome further destruction of insulin-producing cells. Here, we infused adeno-associated virus carrying Pdx1 and MafA expression cassettes through the pancreatic duct to reprogram alpha cells into functional beta cells and normalized blood glucose in both beta cell-toxin-induced diabetic mice and in autoimmune non-obese diabetic (NOD) mice. The euglycemia in toxin-induced diabetic mice and new insulin
+ cells persisted in the autoimmune NOD mice for 4 months prior to reestablishment of autoimmune diabetes. This gene therapy strategy also induced alpha to beta cell conversion in toxin-treated human islets, which restored blood glucose levels in NOD/SCID mice upon transplantation. Hence, this strategy could represent a new therapeutic approach, perhaps complemented by immunosuppression, to bolster endogenous insulin production. Our study thus provides a potential basis for further investigation in human type 1 diabetes., (Copyright © 2017 Elsevier Inc. All rights reserved.)- Published
- 2018
- Full Text
- View/download PDF
30. Identification of Newly Committed Pancreatic Cells in the Adult Mouse Pancreas.
- Author
-
Socorro M, Criscimanna A, Riva P, Tandon M, Prasadan K, Guo P, Humar A, Husain SZ, Leach SD, Gittes GK, and Esni F
- Subjects
- Adult Stem Cells cytology, Adult Stem Cells metabolism, Aldehyde Dehydrogenase 1 Family, Animals, Cadherins metabolism, Cell Differentiation, Gene Expression, Homeodomain Proteins metabolism, Humans, Isoenzymes metabolism, Mice, Inbred C57BL, Mice, Inbred NOD, Mice, Transgenic, Retinal Dehydrogenase metabolism, Thy-1 Antigens metabolism, Trans-Activators metabolism, Pancreas cytology, Pancreas metabolism
- Abstract
Multipotent epithelial cells with high Aldehyde dehydrogenase activity have been previously reported to exist in the adult pancreas. However, whether they represent true progenitor cells remains controversial. In this study, we isolated and characterized cells with ALDH activity in the adult mouse or human pancreas during physiological conditions or injury. We found that cells with ALDH activity are abundant in the mouse pancreas during early postnatal growth, pregnancy, and in mouse models of pancreatitis and type 1 diabetes (T1D). Importantly, a similar population of cells is found abundantly in healthy children, or in patients with pancreatitis or T1D. We further demonstrate that cells with ALDH activity can commit to either endocrine or acinar lineages, and can be divided into four sub-populations based on CD90 and Ecadherin expression. Finally, our in vitro and in vivo studies show that the progeny of ALDH1
+ /CD90- /Ecad- cells residing in the adult mouse pancreas have the ability to initiate Pancreatic and duodenal homeobox (Pdx1) expression for the first time. In summary, we provide evidence for the existence of a sortable population of multipotent non-epithelial cells in the adult pancreas that can commit to the pancreatic lineage following proliferation and mesenchymal to epithelial transition (MET).- Published
- 2017
- Full Text
- View/download PDF
31. Gcg CreERT2 knockin mice as a tool for genetic manipulation in pancreatic alpha cells.
- Author
-
Shiota C, Prasadan K, Guo P, Fusco J, Xiao X, and Gittes GK
- Subjects
- Animals, Female, Glucagon blood, Glucagon-Like Peptide 1 blood, Immunohistochemistry, Male, Mice, Mice, Transgenic, Proglucagon genetics, Tamoxifen pharmacology, Glucagon-Secreting Cells metabolism, Proglucagon metabolism
- Abstract
Aims/hypothesis: The Cre/loxP system, which enables tissue-specific manipulation of genes, is widely used in mice for diabetes research. Our aim was to develop a new Cre-driver mouse line for the specific and efficient manipulation of genes in pancreatic alpha cells., Methods: A Gcg
CreERT2 knockin mouse, which expresses a tamoxifen-inducible form of Cre from the endogenous preproglucagon (Gcg) gene locus, was generated by homologous recombination. The new GcgCreERT2 mouse line was crossed to the Rosa26tdTomato (R26tdTomato ) Cre reporter mouse line in order to evaluate the tissue specificity, efficiency and tamoxifen dependency of GcgCreERT2 -mediated recombination. Cell types of pancreatic islets were identified using immunohistochemistry. Biochemical and physiological data, including blood glucose levels, plasma glucagon and glucagon-like peptide (GLP)-1 levels, and pancreatic glucagon content, were collected and used to assess the overall effect of Gcg gene targeting on GcgCreERT2/w heterozygous mice., Results: Tamoxifen-treated GcgCreERT2/w ;R26tdTomato/w mice displayed Cre reporter activity, i.e. expression of tdTomato red fluorescent protein (RFP) in all known cells that produce proglucagon-derived peptides. In the adult pancreas, RFP was detected in 94-97% of alpha cells, whereas it was detected in a negligible (~ 0.2%) proportion of beta cells. While more than 98% of cells labelled with tamoxifen-induced RFP were glucagon-positive cells, 14-25% of pancreatic polypeptide (PP)-positive cells were also positive for RFP, indicating the presence of glucagon/PP bihormonal cell population. Tamoxifen-independent expression of RFP occurred in approximately 6% of alpha cells. In contrast to alpha cells and GLP-1-producing neurons, in which RFP expression persisted for at least 5 months after tamoxifen administration (presumably due to rare neogenesis in these cell types in adulthood), nearly half of RFP-positive intestinal L cells were replaced with RFP-negative L cells over the first 2 weeks after tamoxifen administration. Heterozygous GcgCreERT2/w mice showed reduced Gcg mRNA levels in islets, but maintained normal levels of pancreatic and plasma glucagon. The mice did not exhibit any detectable baseline physiological abnormalities, at least in young adulthood., Conclusions/interpretation: The newly developed GcgCreERT2 knockin mouse shows faithful expression of CreERT2 in pancreatic alpha cells, intestinal L cells and GLP-1-producing neurons. This mouse line will be particularly useful for manipulating genes in alpha cells, due to highly specific and efficient CreERT2 -mediated recombination in this cell type in the pancreas.- Published
- 2017
- Full Text
- View/download PDF
32. Autophagy protects pancreatic beta cell mass and function in the setting of a high-fat and high-glucose diet.
- Author
-
Sheng Q, Xiao X, Prasadan K, Chen C, Ming Y, Fusco J, Gangopadhyay NN, Ricks D, and Gittes GK
- Subjects
- Animals, Apoptosis drug effects, Blood Glucose, Cell Line, Cell Size, Diet, Diet, High-Fat, Glucose pharmacology, Glucose Tolerance Test, Insulin metabolism, Insulin Resistance, Insulin-Secreting Cells cytology, Insulin-Secreting Cells pathology, Mice, Autophagy drug effects, Autophagy genetics, Dietary Fats metabolism, Glucose metabolism, Insulin-Secreting Cells metabolism
- Abstract
Autophagy is a major regulator of pancreatic beta cell homeostasis. Altered autophagic activity has been implicated in the beta cells of patients with type 2 diabetes, and in the beta cells of obese diabetic rodents. Here, we show that autophagy was induced in beta cells by either a high-fat diet or a combined high-fat and high-glucose diet, but not by high-glucose alone. However, a high-glucose intake alone did increase beta cell mass and insulin secretion moderately. Depletion of Atg7, a necessary component of the autophagy pathway, in beta cells by pancreatic intra-ductal AAV8-shAtg7 infusion in C57BL/6 mice, resulted in decreased beta cell mass, impaired glucose tolerance, defective insulin secretion, and increased apoptosis when a combined high-fat and high-glucose diet was given, seemingly due to suppression of autophagy. Taken together, our findings suggest that the autophagy pathway may act as a protective mechanism in pancreatic beta cells during a high-calorie diet.
- Published
- 2017
- Full Text
- View/download PDF
33. SMAD3/Stat3 Signaling Mediates β-Cell Epithelial-Mesenchymal Transition in Chronic Pancreatitis-Related Diabetes.
- Author
-
Xiao X, Fischbach S, Zhang T, Chen C, Sheng Q, Zimmerman R, Patnaik S, Fusco J, Ming Y, Guo P, Shiota C, Prasadan K, Gangopadhyay N, Husain SZ, Dong H, and Gittes GK
- Subjects
- Animals, Apoptosis physiology, Diabetes Mellitus, Type 1 metabolism, Diabetes Mellitus, Type 1 pathology, Epithelial-Mesenchymal Transition drug effects, Epithelial-Mesenchymal Transition physiology, Insulin-Secreting Cells drug effects, Insulin-Secreting Cells metabolism, Male, Mice, Mice, Inbred C57BL, Pancreatitis, Chronic pathology, STAT3 Transcription Factor genetics, Signal Transduction drug effects, Signal Transduction genetics, Smad3 Protein genetics, Transforming Growth Factor beta1 pharmacology, Pancreatitis, Chronic metabolism, STAT3 Transcription Factor metabolism, Smad3 Protein metabolism
- Abstract
Many patients with chronic pancreatitis develop diabetes (chronic pancreatitis-related diabetes [CPRD]) through an undetermined mechanism. Here we used long-term partial pancreatic duct ligation (PDL) as a model to study CPRD. We found that long-term PDL induced significant β-cell dedifferentiation, followed by a time-dependent decrease in functional β-cell mass-all specifically in the ligated tail portion of the pancreas (PDL-tail). High levels of transforming growth factor β1 (TGFβ1) were detected in the PDL-tail and were mainly produced by M2 macrophages at the early stage and by activated myofibroblasts at the later stage. Loss of β-cell mass was then found to result from TGFβ1-triggered epithelial-mesenchymal transition (EMT) by β-cells, rather than resulting directly from β-cell apoptosis. Mechanistically, TGFβ1-treated β-cells activated expression of the EMT regulator gene Snail in a SMAD3/Stat3-dependent manner. Moreover, forced expression of forkhead box protein O1 (FoxO1), an antagonist for activated Stat3, specifically in β-cells ameliorated β-cell EMT and β-cell loss and prevented the onset of diabetes in mice undergoing PDL. Together, our data suggest that chronic pancreatitis may trigger TGFβ1-mediated β-cell EMT to lead to CPRD, which could substantially be prevented by sustained expression of FoxO1 in β-cells., (© 2017 by the American Diabetes Association.)
- Published
- 2017
- Full Text
- View/download PDF
34. GLP-1/Exendin-4 induces β-cell proliferation via the epidermal growth factor receptor.
- Author
-
Fusco J, Xiao X, Prasadan K, Sheng Q, Chen C, Ming YC, and Gittes G
- Subjects
- Animals, Blood Glucose drug effects, Cell Proliferation drug effects, Cell Size, Cells, Cultured, ErbB Receptors metabolism, Insulin-Secreting Cells metabolism, Mice, Mutation, ErbB Receptors genetics, Exenatide pharmacology, Hypoglycemic Agents pharmacology, Insulin-Secreting Cells cytology
- Abstract
Exendin-4 is a long acting glucagon-like peptide 1 (GLP-1) analogue that is an agonist for the GLP-1 receptor, a G-protein coupled receptor (GPCR). Exendin-4 is used to clinically improve glucose tolerance in diabetic patients due to its ability to enhance insulin secretion. In rodents, and possibly in humans, exendin-4 can stimulate β-cell proliferation. The exact mechanism of action to induce β-cell proliferation is not well understood. Here, using a β-cell specific epidermal growth factor receptor (EGFR) null mouse, we show that exendin-4 induced an increase in proliferation and β-cell mass through EGFR. Thus, our study sheds light on the role of EGFR signaling in the effects of exendin-4 on the control of blood glucose metabolism and β-cell mass.
- Published
- 2017
- Full Text
- View/download PDF
35. Forkhead Box Protein 1 (FoxO1) Inhibits Accelerated β Cell Aging in Pancreas-specific SMAD7 Mutant Mice.
- Author
-
Xiao X, Chen C, Guo P, Zhang T, Fischbach S, Fusco J, Shiota C, Prasadan K, Dong H, and Gittes GK
- Subjects
- Animals, Cell Proliferation, Cellular Senescence, Diabetes Mellitus genetics, Diabetes Mellitus pathology, Forkhead Box Protein O1 genetics, Insulin-Secreting Cells metabolism, Male, Mice, Mice, Knockout, Mice, SCID, Mutation, Pancreas metabolism, Pancreas pathology, Protein Transport, Smad7 Protein genetics, Diabetes Mellitus metabolism, Forkhead Box Protein O1 metabolism, Insulin-Secreting Cells pathology, Smad7 Protein metabolism
- Abstract
The mechanisms underlying the effects of exocrine dysfunction on the development of diabetes remain largely unknown. Here we show that pancreatic depletion of SMAD7 resulted in age-dependent increases in β cell dysfunction with accelerated glucose intolerance, followed by overt diabetes. The accelerated β cell dysfunction and loss of proliferation capacity, two features of β cell aging, appeared to be non-cell-autonomous, secondary to the adjacent exocrine failure as a "bystander effect." Increased Forkhead box protein 1 (FoxO1) acetylation and nuclear retention was followed by progressive FoxO1 loss in β cells that marked the onset of diabetes. Moreover, forced FoxO1 expression in β cells prevented β cell dysfunction and loss in this model. Thus, we present a model of accelerated β cell aging that may be useful for studying the mechanisms underlying β cell failure in diabetes. Moreover, we provide evidence highlighting a critical role of FoxO1 in maintaining β cell identity in the context of SMAD7 failure., (© 2017 by The American Society for Biochemistry and Molecular Biology, Inc.)
- Published
- 2017
- Full Text
- View/download PDF
36. Targeted inhibition of pancreatic acinar cell calcineurin is a novel strategy to prevent post-ERCP pancreatitis.
- Author
-
Orabi AI, Wen L, Javed TA, Le T, Guo P, Sanker S, Ricks D, Boggs K, Eisses JF, Castro C, Xiao X, Prasadan K, Esni F, Gittes GK, and Husain SZ
- Abstract
Background and Aims: There is a pressing need to develop effective preventative therapies for post-ERCP pancreatitis (PEP). We demonstrated that early PEP events are induced through the calcium-activated phosphatase calcineurin and that global calcineurin deletion abolishes PEP in mice. A crucial question is whether acinar cell calcineurin controls the initiation of PEP in vivo ., Methods: We used a mouse model of PEP and examined the effects of in vivo acinar cell-specific calcineurin deletion by either generating a conditional knockout line or infusing a novel AAV-Ela-iCre into the pancreatic duct of a calcineurin floxed line., Results: We found that PEP is dependent on acinar cell calcineurin in vivo , and this led us to determine that calcineurin inhibitors, infused within the radiocontrast, can largely prevent PEP., Conclusions: These results provide impetus for launching clinical trials to test the efficacy of intraductal calcineurin inhibitors to prevent PEP.
- Published
- 2017
- Full Text
- View/download PDF
37. Epidermal Growth Factor Receptor Signaling Regulates β Cell Proliferation in Adult Mice.
- Author
-
Song Z, Fusco J, Zimmerman R, Fischbach S, Chen C, Ricks DM, Prasadan K, Shiota C, Xiao X, and Gittes GK
- Subjects
- Animals, Cyclin D1 genetics, Cyclin D1 metabolism, ErbB Receptors genetics, Mice, Mice, Transgenic, Cell Proliferation physiology, ErbB Receptors metabolism, Insulin-Secreting Cells metabolism, Signal Transduction physiology
- Abstract
A thorough understanding of the signaling pathways involved in the regulation of β cell proliferation is an important initial step in restoring β cell mass in the diabetic patient. Here, we show that epidermal growth factor receptor 1 (EGFR) was significantly up-regulated in the islets of C57BL/6 mice after 50% partial pancreatectomy (PPx), a model for workload-induced β cell proliferation. Specific deletion of EGFR in the β cells of adult mice impaired β cell proliferation at baseline and after 50% PPx, suggesting that the EGFR signaling pathway plays an essential role in adult β cell proliferation. Further analyses showed that β cell-specific depletion of EGFR resulted in impaired expression of cyclin D1 and impaired suppression of p27 after PPx, both of which enhance β cell proliferation. These data highlight the importance of EGFR signaling and its downstream signaling cascade in postnatal β cell growth., (© 2016 by The American Society for Biochemistry and Molecular Biology, Inc.)
- Published
- 2016
- Full Text
- View/download PDF
38. A synopsis of factors regulating beta cell development and beta cell mass.
- Author
-
Prasadan K, Shiota C, Xiangwei X, Ricks D, Fusco J, and Gittes G
- Subjects
- Animals, Humans, Intercellular Signaling Peptides and Proteins metabolism, Organ Size, Signal Transduction, Transcription Factors metabolism, Transforming Growth Factor beta metabolism, Insulin-Secreting Cells cytology, Insulin-Secreting Cells metabolism
- Abstract
The insulin-secreting beta cells in the endocrine pancreas regulate blood glucose levels, and loss of functional beta cells leads to insulin deficiency, hyperglycemia (high blood glucose) and diabetes mellitus. Current treatment strategies for type-1 (autoimmune) diabetes are islet transplantation, which has significant risks and limitations, or normalization of blood glucose with insulin injections, which is clearly not ideal. The type-1 patients can lack insulin counter-regulatory mechanism; therefore, hypoglycemia is a potential risk. Hence, a cell-based therapy offers a better alternative for the treatment of diabetes. Past research was focused on attempting to generate replacement beta cells from stem cells; however, recently there has been an increasing interest in identifying mechanisms that will lead to the conversion of pre-existing differentiated endocrine cells into beta cells. The goal of this review is to provide an overview of several of the key factors that regulate new beta cell formation (neogenesis) and beta cell proliferation.
- Published
- 2016
- Full Text
- View/download PDF
39. Transient Suppression of TGFβ Receptor Signaling Facilitates Human Islet Transplantation.
- Author
-
Xiao X, Fischbach S, Song Z, Gaffar I, Zimmerman R, Wiersch J, Prasadan K, Shiota C, Guo P, Ramachandran S, Witkowski P, and Gittes GK
- Subjects
- Animals, Benzamides pharmacology, Blood Glucose metabolism, Blotting, Western, C-Peptide metabolism, Cell Proliferation drug effects, Cells, Cultured, Dioxoles pharmacology, Female, Humans, Insulin blood, Insulin metabolism, Insulin-Secreting Cells drug effects, Insulin-Secreting Cells metabolism, Islets of Langerhans drug effects, Mice, Inbred NOD, Mice, SCID, Microscopy, Confocal, Protein Serine-Threonine Kinases antagonists & inhibitors, Receptor, Transforming Growth Factor-beta Type I, Receptors, Transforming Growth Factor beta antagonists & inhibitors, Signal Transduction drug effects, Transplantation, Heterologous, Islets of Langerhans metabolism, Islets of Langerhans Transplantation methods, Protein Serine-Threonine Kinases metabolism, Receptors, Transforming Growth Factor beta metabolism, Signal Transduction physiology
- Abstract
Although islet transplantation is an effective treatment for severe diabetes, its broad application is greatly limited due to a shortage of donor islets. Suppression of TGFβ receptor signaling in β-cells has been shown to increase β-cell proliferation in mice, but has not been rigorously examined in humans. Here, treatment of human islets with a TGFβ receptor I inhibitor, SB-431542 (SB), significantly improved C-peptide secretion by β-cells, and significantly increased β-cell number by increasing β-cell proliferation. In addition, SB increased cell-cycle activators and decreased cell-cycle suppressors in human β-cells. Transplantation of SB-treated human islets into diabetic immune-deficient mice resulted in significant improvement in blood glucose control, significantly higher serum and graft insulin content, and significantly greater increases in β-cell proliferation in the graft, compared with controls. Thus, our data suggest that transient suppression of TGFβ receptor signaling may improve the outcome of human islet transplantation, seemingly through increasing β-cell number and function.
- Published
- 2016
- Full Text
- View/download PDF
40. PNA lectin for purifying mouse acinar cells from the inflamed pancreas.
- Author
-
Xiao X, Fischbach S, Fusco J, Zimmerman R, Song Z, Nebres P, Ricks DM, Prasadan K, Shiota C, Husain SZ, and Gittes GK
- Subjects
- Acinar Cells metabolism, Animals, Flow Cytometry methods, Mice, Pancreas pathology, Acinar Cells cytology, Cell Separation methods, Pancreas cytology, Pancreatitis pathology, Peanut Agglutinin metabolism
- Abstract
Better methods for purifying human or mouse acinar cells without the need for genetic modification are needed. Such techniques would be advantageous for the specific study of certain mechanisms, such as acinar-to-beta-cell reprogramming and pancreatitis. Ulex Europaeus Agglutinin I (UEA-I) lectin has been used to label and isolate acinar cells from the pancreas. However, the purity of the UEA-I-positive cell fraction has not been fully evaluated. Here, we screened 20 widely used lectins for their binding specificity for major pancreatic cell types, and found that UEA-I and Peanut agglutinin (PNA) have a specific affinity for acinar cells in the mouse pancreas, with minimal affinity for other major pancreatic cell types including endocrine cells, duct cells and endothelial cells. Moreover, PNA-purified acinar cells were less contaminated with mesenchymal and inflammatory cells, compared to UEA-I purified acinar cells. Thus, UEA-I and PNA appear to be excellent lectins for pancreatic acinar cell purification. PNA may be a better choice in situations where mesenchymal cells or inflammatory cells are significantly increased in the pancreas, such as type 1 diabetes, pancreatitis and pancreatic cancer.
- Published
- 2016
- Full Text
- View/download PDF
41. Dynamic imaging of pancreatic nuclear factor κB (NF-κB) activation in live mice using adeno-associated virus (AAV) infusion and bioluminescence.
- Author
-
Orabi AI, Sah S, Javed TA, Lemon KL, Good ML, Guo P, Xiao X, Prasadan K, Gittes GK, Jin S, and Husain SZ
- Published
- 2016
- Full Text
- View/download PDF
42. Intraislet Pancreatic Ducts Can Give Rise to Insulin-Positive Cells.
- Author
-
El-Gohary Y, Wiersch J, Tulachan S, Xiao X, Guo P, Rymer C, Fischbach S, Prasadan K, Shiota C, Gaffar I, Song Z, Galambos C, Esni F, and Gittes GK
- Subjects
- Adolescent, Age Factors, Animals, Cadaver, Child, Preschool, Female, Humans, Infant, Insulin-Secreting Cells physiology, Islets of Langerhans growth & development, Islets of Langerhans physiology, Luminescent Proteins genetics, Luminescent Proteins metabolism, Male, Mice, Mutant Strains, Mice, Transgenic, Mutant Proteins genetics, Mutant Proteins metabolism, Pancreatectomy, Pancreatic Ducts growth & development, Pancreatic Ducts physiology, Protein Serine-Threonine Kinases genetics, Receptor, Transforming Growth Factor-beta Type II, Receptors, Transforming Growth Factor beta genetics, Regeneration, Red Fluorescent Protein, Cell Transdifferentiation, Insulin biosynthesis, Insulin-Secreting Cells cytology, Islets of Langerhans cytology, Pancreatic Ducts cytology, Protein Serine-Threonine Kinases metabolism, Receptors, Transforming Growth Factor beta metabolism
- Abstract
A key question in diabetes research is whether new β-cells can be derived from endogenous, nonendocrine cells. The potential for pancreatic ductal cells to convert into β-cells is a highly debated issue. To date, it remains unclear what anatomical process would result in duct-derived cells coming to exist within preexisting islets. We used a whole-mount technique to directly visualize the pancreatic ductal network in young wild-type mice, young humans, and wild-type and transgenic mice after partial pancreatectomy. Pancreatic ductal networks, originating from the main ductal tree, were found to reside deep within islets in young mice and humans but not in mature mice or humans. These networks were also not present in normal adult mice after partial pancreatectomy, but TGF-β receptor mutant mice demonstrated formation of these intraislet duct structures after partial pancreatectomy. Genetic and viral lineage tracings were used to determine whether endocrine cells were derived from pancreatic ducts. Lineage tracing confirmed that pancreatic ductal cells can typically convert into new β-cells in normal young developing mice as well as in adult TGF-β signaling mutant mice after partial pancreatectomy. Here the direct visual evidence of ducts growing into islets, along with lineage tracing, not only represents strong evidence for duct cells giving rise to β-cells in the postnatal pancreas but also importantly implicates TGF-β signaling in this process.
- Published
- 2016
- Full Text
- View/download PDF
43. Dynamic imaging of pancreatic nuclear factor κB (NF-κB) activation in live mice using adeno-associated virus (AAV) infusion and bioluminescence.
- Author
-
Orabi AI, Sah S, Javed TA, Lemon KL, Good ML, Guo P, Xiao X, Prasadan K, Gittes GK, Jin S, and Husain SZ
- Subjects
- Animals, Ceruletide metabolism, Dependovirus physiology, HEK293 Cells, Humans, Luciferases genetics, Mice, Mice, Transgenic, NF-kappa B genetics, Organ Specificity, Signal Transduction, Dependovirus genetics, Luminescent Measurements, Molecular Imaging, NF-kappa B metabolism, Pancreas metabolism, Pancreas virology
- Abstract
Nuclear factor κB (NF-κB) is an important signaling molecule that plays a critical role in the development of acute pancreatitis. Current methods for examining NF-κB activation involve infection of an adenoviral NF-κB-luciferase reporter into cell lines or electrophoretic mobility shift assay of lysate. The use of adeno-associated viruses (AAVs) has proven to be an effective method of transfecting whole organs in live animals. We examined whether intrapancreatic duct infusion of AAV containing an NF-κB-luciferase reporter (AAV-NF-κB-luciferase) can reliably measure pancreatic NF-κB activation. We confirmed the infectivity of the AAV-NF-κB-luciferase reporter in HEK293 cells using a traditional luciferase readout. Mice were infused with AAV-NF-κB-luciferase 5 weeks before induction of pancreatitis (caerulein, 50 μg/kg). Unlike transgenic mice that globally express NF-κB-luciferase, AAV-infused mice showed a 15-fold increase in pancreas-specific NF-κB bioluminescence following 12 h of caerulein compared with baseline luminescence (p < 0.05). The specificity of the NF-κB-luciferase signal to the pancreas was confirmed by isolating the pancreas and adjacent organs and observing a predominant bioluminescent signal in the pancreas compared with liver, spleen, and stomach. A complementary mouse model of post-ERCP-pancreatitis also induced pancreatic NF-κB signals. Taken together these data provide the first demonstration that NF-κB activation can be examined in a live, dynamic fashion during pancreatic inflammation. We believe this technique offers a valuable tool to study real-time activation of NF-κB in vivo., (© 2015 by The American Society for Biochemistry and Molecular Biology, Inc.)
- Published
- 2015
- Full Text
- View/download PDF
44. Pancreatic cell tracing, lineage tagging and targeted genetic manipulations in multiple cell types using pancreatic ductal infusion of adeno-associated viral vectors and/or cell-tagging dyes.
- Author
-
Xiao X, Guo P, Prasadan K, Shiota C, Peirish L, Fischbach S, Song Z, Gaffar I, Wiersch J, El-Gohary Y, Husain SZ, and Gittes GK
- Subjects
- Animals, Cell Lineage, Dimethylamines administration & dosage, Female, Genetic Techniques, Laparotomy, Male, Mice, Inbred C57BL, Mice, Transgenic, Pancreatic Ducts physiology, Promoter Regions, Genetic, RNA, Small Interfering, Transduction, Genetic, Transgenes, Coloring Agents administration & dosage, Dependovirus genetics, Genetic Vectors, Pancreas cytology, Pancreatic Ducts surgery
- Abstract
Genetic manipulations, with or without lineage tracing for specific pancreatic cell types, are very powerful tools for studying diabetes, pancreatitis and pancreatic cancer. Nevertheless, the use of Cre/loxP systems to conditionally activate or inactivate the expression of genes in a cell type- and/or temporal-specific manner is not applicable to cell tracing and/or gene manipulations in more than one lineage at a time. Here we report a technique that allows efficient delivery of dyes for cell tagging into the mouse pancreas through the duct system, and that also delivers viruses carrying transgenes or siRNA under a specific promoter. When this technique is applied in genetically modified mice, it enables the investigator to perform either double lineage tracing or cell lineage tracing combined with gene manipulation in a second lineage. The technique requires <40 min.
- Published
- 2014
- Full Text
- View/download PDF
45. Pancreatic duct cells as a source of VEGF in mice.
- Author
-
Xiao X, Prasadan K, Guo P, El-Gohary Y, Fischbach S, Wiersch J, Gaffar I, Shiota C, and Gittes GK
- Subjects
- Animals, Epithelial Cells cytology, Gene Knockdown Techniques, Human Umbilical Vein Endothelial Cells, Humans, Islets of Langerhans cytology, Islets of Langerhans Transplantation, Mice, Neovascularization, Physiologic, RNA, Small Interfering metabolism, SOX9 Transcription Factor genetics, Vascular Endothelial Growth Factor A genetics, Insulin-Secreting Cells metabolism, Pancreatic Ducts metabolism, Vascular Endothelial Growth Factor A metabolism
- Abstract
Aims/hypothesis: Vascular endothelial growth factor (VEGF) is essential for proper pancreatic development, islet vascularisation and insulin secretion. In the adult pancreas, VEGF is thought to be predominantly secreted by beta cells. Although human duct cells have previously been shown to secrete VEGF at angiogenic levels in culture, an analysis of the kinetics of VEGF synthesis and secretion, as well as elucidation of an in vivo role for this ductal VEGF in affecting islet function and physiology, has been lacking., Methods: We analysed purified duct cells independently prepared by flow cytometry, surgical isolation or laser-capture microdissection. We infected duct cells in vivo with Vegf (also known as Vegfa) short hairpin RNA (shRNA) in an intrapancreatic ductal infusion system and examined the effect of VEGF knockdown in duct cells in vitro and in vivo., Results: Pancreatic duct cells express high levels of Vegf mRNA. Compared with beta cells, duct cells had a much higher ratio of secreted to intracellular VEGF. As a bioassay, formation of tubular structures by human umbilical vein endothelial cells was essentially undetectable when cultured alone and was substantially increased when co-cultured with pancreatic duct cells but significantly reduced when co-cultured with duct cells pretreated with Vegf shRNA. Compared with islets transplanted alone, improved vascularisation and function was detected in the islets co-transplanted with duct cells but not in islets co-transplanted with duct cells pretreated with Vegf shRNA., Conclusions/interpretation: Human islet preparations for transplantation typically contain some contaminating duct cells and our findings suggest that the presence of duct cells in the islet preparation may improve transplantation outcomes.
- Published
- 2014
- Full Text
- View/download PDF
46. M2 macrophages promote beta-cell proliferation by up-regulation of SMAD7.
- Author
-
Xiao X, Gaffar I, Guo P, Wiersch J, Fischbach S, Peirish L, Song Z, El-Gohary Y, Prasadan K, Shiota C, and Gittes GK
- Subjects
- Animals, Cell Movement, Cell Nucleus metabolism, Cell Proliferation, Cyclin-Dependent Kinase Inhibitor p27 metabolism, Disease Models, Animal, ErbB Receptors metabolism, Inflammation metabolism, Inflammation pathology, Ligation, Mice, Mice, Inbred C57BL, Models, Biological, Signal Transduction, Transforming Growth Factor beta metabolism, Insulin-Secreting Cells metabolism, Insulin-Secreting Cells pathology, Macrophages metabolism, Smad7 Protein metabolism, Up-Regulation
- Abstract
Determination of signaling pathways that regulate beta-cell replication is critical for beta-cell therapy. Here, we show that blocking pancreatic macrophage infiltration after pancreatic duct ligation (PDL) completely inhibits beta-cell proliferation. The TGFβ superfamily signaling inhibitor SMAD7 was significantly up-regulated in beta cells after PDL. Beta cells failed to proliferate in response to PDL in beta-cell-specific SMAD7 mutant mice. Forced expression of SMAD7 in beta cells by itself was sufficient to promote beta-cell proliferation in vivo. M2, rather than M1 macrophages, seem to be the inducers of SMAD7-mediated beta-cell proliferation. M2 macrophages not only release TGFβ1 to directly induce up-regulation of SMAD7 in beta cells but also release EGF to activate EGF receptor signaling that inhibits TGFβ1-activated SMAD2 nuclear translocation, resulting in TGFβ signaling inhibition. SMAD7 promotes beta-cell proliferation by increasing CyclinD1 and CyclinD2, and by inducing nuclear exclusion of p27. Our study thus reveals a molecular pathway to potentially increase beta-cell mass through enhanced SMAD7 activity induced by extracellular stimuli.
- Published
- 2014
- Full Text
- View/download PDF
47. A smad signaling network regulates islet cell proliferation.
- Author
-
El-Gohary Y, Tulachan S, Wiersch J, Guo P, Welsh C, Prasadan K, Paredes J, Shiota C, Xiao X, Wada Y, Diaz M, and Gittes G
- Subjects
- Animals, Cell Proliferation, Insulin-Secreting Cells cytology, Mice, Mice, Transgenic, Phosphorylation, Receptors, Transforming Growth Factor beta metabolism, Smad Proteins genetics, Transforming Growth Factor beta metabolism, Cell Dedifferentiation physiology, Insulin-Secreting Cells metabolism, Signal Transduction physiology, Smad Proteins metabolism
- Abstract
Pancreatic β-cell loss and dysfunction are critical components of all types of diabetes. Human and rodent β-cells are able to proliferate, and this proliferation is an important defense against the evolution and progression of diabetes. Transforming growth factor-β (TGF-β) signaling has been shown to affect β-cell development, proliferation, and function, but β-cell proliferation is thought to be the only source of new β-cells in the adult. Recently, β-cell dedifferentiation has been shown to be an important contributory mechanism to β-cell failure. In this study, we tie together these two pathways by showing that a network of intracellular TGF-β regulators, smads 7, 2, and 3, control β-cell proliferation after β-cell loss, and specifically, smad7 is necessary for that β-cell proliferation. Importantly, this smad7-mediated proliferation appears to entail passing through a transient, nonpathologic dedifferentiation of β-cells to a pancreatic polypeptide-fold hormone-positive state. TGF-β receptor II appears to be a receptor important for controlling the status of the smad network in β-cells. These studies should help our understanding of properly regulated β-cell replication.
- Published
- 2014
- Full Text
- View/download PDF
48. Specific transduction and labeling of pancreatic ducts by targeted recombinant viral infusion into mouse pancreatic ducts.
- Author
-
Guo P, Xiao X, El-Gohary Y, Criscimanna A, Prasadan K, Rymer C, Shiota C, Wiersch J, Gaffar I, Esni F, and Gittes GK
- Subjects
- Animals, Cell Lineage, Genetic Vectors, Green Fluorescent Proteins genetics, HEK293 Cells, Humans, Infusion Pumps, Mice, Pancreas cytology, Pancreas metabolism, Pancreatic Ducts cytology, Promoter Regions, Genetic, Recombinant Proteins genetics, Regeneration, SOX9 Transcription Factor genetics, Transduction, Genetic instrumentation, Dependovirus genetics, Pancreatic Ducts metabolism, Transduction, Genetic methods
- Abstract
Specific labeling of pancreatic ducts has proven to be quite difficult. Such labeling has been highly sought after because of the power it would confer to studies of pancreatic ductal carcinogenesis, as well as studies of the source of new insulin-producing β-cells. Cre-loxp recombination could, in theory, lineage-tag pancreatic ducts, but results have been conflicting, mainly due to low labeling efficiencies. Here, we achieved a high pancreatic duct labeling efficiency using a recombinant adeno-associated virus (rAAV) with a duct-specific sox9 promoter infused into the mouse common biliary/pancreatic duct. We saw rapid, diffuse duct-specific labeling, with 50 and 89% labeling in the pancreatic tail and head region, respectively. This highly specific labeling of ducts should greatly enhance our ability to study the role of pancreatic ducts in numerous aspects of pancreatic growth, development and function.
- Published
- 2013
- Full Text
- View/download PDF
49. α-Cells are dispensable in postnatal morphogenesis and maturation of mouse pancreatic islets.
- Author
-
Shiota C, Prasadan K, Guo P, El-Gohary Y, Wiersch J, Xiao X, Esni F, and Gittes GK
- Subjects
- Ablation Techniques, Animals, Animals, Newborn, Biomarkers metabolism, Exons, Female, Glucagon chemistry, Glucagon genetics, Glucose Transporter Type 2 metabolism, Hypertrophy, Hypoglycemia etiology, Insulin-Secreting Cells cytology, Insulin-Secreting Cells metabolism, Islets of Langerhans cytology, Islets of Langerhans surgery, Luminescent Proteins chemistry, Luminescent Proteins metabolism, Male, Mice, Mice, Transgenic, Pancreas pathology, Peptide Fragments chemistry, Peptide Fragments genetics, Peptide Fragments metabolism, Promoter Regions, Genetic, Recombinant Fusion Proteins metabolism, Urocortins metabolism, Glucagon metabolism, Glucagon-Secreting Cells physiology, Islets of Langerhans growth & development
- Abstract
Glucagon-producing α-cells are the second-most abundant cell type in the islet. Whereas α-cells make up less than 20% of the cells in a mature mouse islet, they occupy a much larger proportion of the pancreatic endocrine cell population during the early postnatal period, the time when morphological and functional maturation occurs to form adult islets. To determine whether α-cells have a role in postnatal islet development, a diphtheria toxin-mediated α-cell ablation mouse model was established. Rapid and persistent depletion of α-cells was achieved by daily injection of the toxin for 2 wk starting at postnatal day 1 (P1). Total pancreatic glucagon content in the α-cell-ablated mice was undetectable at P14 and still less than 0.3% of that of the control mice at 4 mo of age. Histological analyses revealed that formation of spherical islets occurred normally, and the islet size distribution was not changed despite the near-total lack of α-cells. Furthermore, there were no differences in expression of β-cell maturation marker proteins, including urocortin 3 and glucose transporter 2, in the α-cell-ablated islets at P14. Mice lacking α-cells grew normally and appeared healthy. Both glucose and insulin tolerance tests demonstrated that the α-cell-ablated mice had normal glucose homeostasis. These results indicate that α-cells do not play a critical role in postnatal islet morphogenesis or functional maturation of β-cells.
- Published
- 2013
- Full Text
- View/download PDF
50. Neurogenin3 activation is not sufficient to direct duct-to-beta cell transdifferentiation in the adult pancreas.
- Author
-
Xiao X, Guo P, Shiota C, Prasadan K, El-Gohary Y, Wiersch J, Gaffar I, and Gittes GK
- Subjects
- Animals, Basic Helix-Loop-Helix Transcription Factors genetics, Fluoresceins pharmacology, Fluorescent Dyes pharmacology, Insulin-Secreting Cells cytology, Mice, Mice, Transgenic, Nerve Tissue Proteins genetics, Pancreatic Ducts cytology, Succinimides pharmacology, Basic Helix-Loop-Helix Transcription Factors metabolism, Cell Transdifferentiation physiology, Insulin-Secreting Cells metabolism, Nerve Tissue Proteins metabolism, Pancreatic Ducts metabolism
- Abstract
It remains controversial whether adult pancreatic ducts harbor facultative beta cell progenitors. Because neurogenin3 (Ngn3) is a key determinant of pancreatic endocrine cell neogenesis during embryogenesis, many studies have also relied upon Ngn3 expression as evidence of beta cell neogenesis in adults. Recently, however, Ngn3 as a marker of adult beta cell neogenesis has been called into question by reports of Ngn3 expression in fully-developed beta cells. Nevertheless, direct evidence as to whether Ngn3 activation in adult pancreatic duct cells may lead to duct-to-beta cell transdifferentiation is lacking. Here we studied two models of Ngn3 activation in adult pancreatic duct cells (low-dose alloxan treatment and pancreatic duct ligation) and lineage-traced Ngn3-activated duct cells by labeling them through intraductal infusion with a cell-tagging dye, CFDA-SE No dye-labeled beta cells were found during the follow-up in either model, suggesting that activation of Ngn3 in duct cells is not sufficient to direct their transdifferentiation into beta cells. Therefore, Ngn3 activation in duct cells is not a signature for adult beta cell neogenesis.
- Published
- 2013
- Full Text
- View/download PDF
Catalog
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.